The company is commercialising novel Car T-cell therapy developed in New Zealand for cancer and other patients.
New fund aimed at both Icehouse portfolio companies and outside contenders.
Early-stage, deep-tech investment fund is open to retail investors again.
Erik Engelson brings more than 40 years of industry experience to the business.
New WNT Ventures partner MJ Alvarez on the gap between science and venture capital.
New Zealand the latest country to dismiss attempt to overturn decision not to recognise a machine as inventor.
Former Weta Digital artists’ company receives more funding from Hillfarrance.
WorkflowMax’s brand only will be taken on by BlueRock, so competition for departing Xero customers is hot.
Flights of the Mk-II Aurora spaceplane will begin within a month.
New Zealand’s public science system is ‘over-competitive and fragmented,’ he says.